How much funding has Celsius Therapeutics raised?

Celsius Therapeutics has raised $148.0M in total funding, most recently a Series B round.

Who are Celsius Therapeutics's investors?

Celsius Therapeutics's investors include Casdin Capital, Third Rock Ventures, AbbVie Ventures, Amplitude Ventures, GV.

When was Celsius Therapeutics founded?

Celsius Therapeutics was founded in 2018.

Where is Celsius Therapeutics headquartered?

Celsius Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Celsius Therapeutics in?

Celsius Therapeutics operates in Biotech.

How many employees does Celsius Therapeutics have?

Celsius Therapeutics has 11-50 employees.

Celsius Therapeutics

Closed

On a quest to leverage the power of single cell genomics

Cambridge, United States · Founded 2018 · $148.0M raised

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: celsiustx.com
Total Funding: $148.0M
Last Round: $83.0M Series BMar 2022
Rounds: 2

About

Celsius Therapeutics was a biotechnology company that leveraged single-cell RNA sequencing and genomic analysis to identify novel drug targets and develop precision medicines for complex diseases including autoimmunity and cancer. Founded in 2018 and headquartered in Cambridge, Massachusetts, the company built a human tissue-based platform combining scRNA-seq with machine learning to characterize disease biology at the cellular level. Celsius was acquired by AbbVie in June 2024.

Summary

Celsius Therapeutics is a Biotech company based in Cambridge, United States, founded in 2018. It has raised $148.0M in total across 2 rounds, most recently a $83.0M Series B round in Mar 2022. Investors include Casdin Capital, Third Rock Ventures and AbbVie Ventures.

LinkedIn X (Twitter)GitHub